Ezra Lowe
Company: Galectin Therapeutics
Job title: Vice President
Seminars:
Workshop E: Illuminating Novel Target Identification for MASH 2:30 pm
Explore the latest advancements in identifying genetic targets and protein-based therapies for MASH. Devling into the power of machine learning and data at scale to decode the complexities of MASH. Aswell as the inhibition of the Galectin-3 protein as a novel target for the treatment of MASH.Read more
day: Pre Clinical Track Workshop E